compounding semaglutide fda enforcement news today New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our The FDA's Decision to Ban

In one study, people without diabetes who took semaglutide (the active ingredient in Ozempic and Wegovy) were slightly more likely to be diagnosed with ED than those taking a placebo

they can also improve metabolic health by lowering inflammation in the body and boosting weight loss, which can make it easier to manage the condition

Theres a distinct difference between purity and potency, says Lambert

doi:10.4093/dmj.2025.0242 60

Since May 2018, she has been contributing to Medical Dialogues, writing and editing medical news articles that translate complex research into clear, accessible information for healthcare professionals

GLP-1 RAs work by mimicking the effects of GLP-1 to lower blood sugar and decrease appetite